Drug-resistant tuberculosis: time for visionary political leadership

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug re...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet infectious diseases Vol. 13; no. 6; pp. 529 - 539
Main Authors:	Abubakar, Ibrahim, Zignol, Matteo, Falzon, Dennis, Raviglione, Mario, Ditiu, Lucica, Masham, Susan, Adetifa, Ifedayo, Ford, Nathan, Cox, Helen, Lawn, Stephen D, Marais, Ben J, McHugh, Timothy D, Mwaba, Peter, Bates, Matthew, Lipman, Marc, Zijenah, Lynn, Logan, Simon, McNerney, Ruth, Zumla, Adam, Sarda, Krishna, Nahid, Payam, Hoelscher, Michael, Pletschette, Michel, Memish, Ziad A, Kim, Peter, Hafner, Richard, Cole, Stewart, Migliori, Giovanni Battista, Maeurer, Markus, Schito, Marco, Zumla, Alimuddin
Format:	Journal Article
Language:	English
Published:	London Elsevier Ltd 01.06.2013 Lancet Publishing Group Elsevier Limited
Subjects:	Antitubercular Agents - therapeutic use Bacterial diseases Biological and medical sciences Drug resistance Epidemics Global Health Human bacterial diseases Human immunodeficiency virus Humans Infectious Disease Infectious diseases Medical sciences Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - isolation & purification Pandemics Prevalence Public health Tuberculosis Tuberculosis and atypical mycobacterial infections Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology World Health Organization Infection Resistance Bacteriosis Tuberculosis Mycobacterial infection
ISSN:	1473-3099, 1474-4457, 1474-4457
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!